These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29749269)

  • 1. CMS hospital readmission reduction program and anticoagulants received following a total hip and knee arthroplasty discharge.
    Laliberté F; Coleman CI; Bookhart B; Schein J; Martin S; Wynant W; Xiao Y; Lefebvre P; Kaatz S
    Curr Med Res Opin; 2018 Nov; 34(11):1967-1974. PubMed ID: 29749269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program.
    Li BY; Urish KL; Jacobs BL; He C; Borza T; Qin Y; Min HS; Dupree JM; Ellimoottil C; Hollenbeck BK; Lavieri MS; Helm JE; Skolarus TA
    JAMA Netw Open; 2019 Nov; 2(11):e1916008. PubMed ID: 31755949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program.
    Ramaswamy A; Marchese M; Cole AP; Harmouch S; Friedlander D; Weissman JS; Lipsitz SR; Haider AH; Kibel AS; Schoenfeld AJ; Trinh QD
    JAMA Netw Open; 2019 May; 2(5):e194634. PubMed ID: 31150074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
    Bawa H; Weick JW; Dirschl DR; Luu HH
    J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Risk Reduction Initiatives on Readmission: THA and TKA Readmission Rates.
    Keeney JA; Nam D; Johnson SR; Nunley RM; Clohisy JC; Barrack RL
    J Arthroplasty; 2015 Dec; 30(12):2057-60. PubMed ID: 26111791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and Costs of 90-Day Readmission for Surgical and Medical Complications Following Total Hip and Knee Arthroplasty.
    Schwarzkopf R; Behery OA; Yu H; Suter LG; Li L; Horwitz LI
    J Arthroplasty; 2019 Oct; 34(10):2304-2307. PubMed ID: 31279598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Observation Status Versus Readmission in Elective Total Knee and Hip Arthroplasty Returns to Hospital: A Single-Institution Perspective.
    Goode AE; Owen TM; Moskal JT; Miller TK
    J Arthroplasty; 2019 Oct; 34(10):2297-2303.e3. PubMed ID: 31300184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital Discharge within 2 Days Following Total Hip or Knee Arthroplasty Does Not Increase Major-Complication and Readmission Rates.
    Sutton JC; Antoniou J; Epure LM; Huk OL; Zukor DJ; Bergeron SG
    J Bone Joint Surg Am; 2016 Sep; 98(17):1419-28. PubMed ID: 27605685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Validity of All-Cause 30-Day Readmission Rate as a Hospital Performance Metric After Primary Total Hip and Knee Arthroplasty: A Systematic Review.
    Ali AM; Bottle A
    J Arthroplasty; 2019 Aug; 34(8):1831-1836. PubMed ID: 31072744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.
    Hoffman GJ; Yakusheva O
    JAMA Netw Open; 2020 Apr; 3(4):e202044. PubMed ID: 32242906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.
    Roger C; Debuyzer E; Dehl M; Bulaïd Y; Lamrani A; Havet E; Mertl P
    Orthop Traumatol Surg Res; 2019 Sep; 105(5):949-955. PubMed ID: 31208932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has Health Care Reform Legislation Reduced the Economic Burden of Hospital Readmissions Following Primary Total Joint Arthroplasty?
    Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
    J Arthroplasty; 2017 Nov; 32(11):3274-3285. PubMed ID: 28669571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for readmission following primary total hip and total knee arthroplasty.
    Phruetthiphat OA; Otero JE; Zampogna B; Vasta S; Gao Y; Callaghan JJ
    J Orthop Surg (Hong Kong); 2020; 28(3):2309499020959160. PubMed ID: 33021145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of Hospitalization After Joint Arthroplasty: Does Early Discharge Affect Complications and Readmission Rates?
    Otero JE; Gholson JJ; Pugely AJ; Gao Y; Bedard NA; Callaghan JJ
    J Arthroplasty; 2016 Dec; 31(12):2714-2725. PubMed ID: 27600301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will Medicare Readmission Penalties Motivate Hospitals to Reduce Arthroplasty Readmissions?
    Clement RC; Gray CM; Kheir MM; Derman PB; Speck RM; Levin LS; Fleisher LA
    J Arthroplasty; 2017 Mar; 32(3):709-713. PubMed ID: 27712937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Opioid Use Is Associated with Higher Readmission and Revision Rates in Total Knee and Total Hip Arthroplasty.
    Weick J; Bawa H; Dirschl DR; Luu HH
    J Bone Joint Surg Am; 2018 Jul; 100(14):1171-1176. PubMed ID: 30020122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes and Costs Within 90 Days of Primary or Revision Total Joint Arthroplasty.
    Nichols CI; Vose JG
    J Arthroplasty; 2016 Jul; 31(7):1400-1406.e3. PubMed ID: 26880328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Patterns of Anticoagulation After Total Hip Arthroplasty in the United States: Frequency of Deep Vein Thrombosis, Pulmonary Embolism, and Complications With Rivaroxaban and Warfarin.
    Glassberg MB; Lachiewicz PF
    J Arthroplasty; 2019 Aug; 34(8):1793-1801. PubMed ID: 31005440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skilled Nursing Facility Star Rating, Patient Outcomes, and Readmission Risk After Total Joint Arthroplasty.
    Kimball CC; Nichols CI; Nunley RM; Vose JG; Stambough JB
    J Arthroplasty; 2018 Oct; 33(10):3130-3137. PubMed ID: 30001882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.